Abstract:Cistanche tubulosa is a traditional Chinese herbal medicine that is widely used to regulate immunity, and phenylethanol glycosides (CPhGs) are among the primary components responsible for this activity. However, the application of CPhGs is negatively affected by their poor absorption and low oral utilization. Targeted drug delivery is an important development direction for pharmaceutics. Previous studies have indicated that CPhGs could block the conduction of the signaling pathways in TGF-β1/smad and inhibit the activation of hepatic stellate cells (HSCs). The aim of this study was to evaluate the anti-hepatic fibrosis effect of CPhG liposomes by inhibiting HSC activation, promoting apoptosis, blocking the cell cycle, suppressing the conduction of signaling pathways in focal adhesion kinase(FAK)/phosphatidylinositol-3-kinase(PI3K)/protein kinase B(Akt), and determining their in vitro hepatoprotective activity. In vitro release studies demonstrated that CPhG liposomes have a sustained release effect compared to drug CPhGs. HSC proliferation was inhibited after treatment with the CPhG liposomes (29.45, 14.72, 7.36 µg/mL), with IC50 values of 42.54 µg/mL in the MTT assay. Different concentrations of the CPhG liposomes could inhibit HSC proliferation, promote apoptosis, and block the cell cycle. The MTT method showed an obvious inhibition of HSC proliferation after CPhG liposome and Recombinant Rat Platelet-derived growth factor-BB(rrPDGF-BB) treatment. The levels of collagen-1, metallopeptidase inhibitor 1 (TIMP-1), α smooth muscle actin (α-SMA), and phosphorylated PI3K/Akt were downregulated, and matrix metalloproteinase-1 (MMP-1) was upregulated, by pretreatment with different concentrations of CPhG liposomes. Moreover, 29.45 μg/mL of CPhG liposomes could decrease the expression of the FAK protein and the phosphorylated PI3K and Akt protein downstream of FAK by overexpression of the FAK gene. This experiment suggests that CPhG liposomes may inhibit the activation of HSCs by inhibiting FAK and then reducing the expression of phosphorylated Akt/PI3K, thereby providing new insights into the application of CPhGs for liver fibrosis.

Hepatocyte Growth Factor Protects Endothelial Progenitor Cell from Damage of Low-Density Lipoprotein Cholesterol Via the PI3K/Akt Signaling Pathway.

Number and Activity of Endothelial Progenitor Cells from Peripheral Blood in Patients with Hypercholesterolaemia

Hypoxia Confers Protection Against Apoptosis Via the PI3K/Akt Pathway in Endothelial Progenitor Cells.

PKC/NADPH Oxidase Are Involved in the Protective Effect of Pioglitazone in High Homocysteine-Induced Paracrine Dyfunction in Endothelial Progenitor Cells.

Atorvastatin enhances endothelial cell function in posttransplant poor graft function.

Effects of Oxidative Low-Density Lipoprotein on Number and Function of Endothelial Progenitor Cells from Peripheral Blood

Endothelial Progenitor Cells May Inhibit Apoptosis of Pulmonary Microvascular Endothelial Cells: New Insights into Cell Therapy for Pulmonary Arterial Hypertension

Over-expression of Hepatocyte Growth Factor in Smooth Muscle Cells Regulates Endothelial Progenitor Cells Differentiation, Migration and Proliferation

Hepatocyte growth factor plays a critical role in the regulation of cytokine production and induction of endothelial progenitor cell mobilization: a pilot gene therapy study in patients with coronary heart disease.

Over-expression of PDGFR-β Promotes PDGF-induced Proliferation, Migration, and Angiogenesis of EPCs Through PI3K/Akt Signaling Pathway.

The Phenylethanol Glycoside Liposome Inhibits PDGF-Induced HSC Activation Via Regulation of the FAK/PI3K/Akt Signaling Pathway.

Inhibition of HES-1 Might Play a Protective Role in Endothelial Cells under Cholesterol Stimulation Via PI3K/AKT Signaling Pathway

Glucagon-like Peptide-1 Improves Proliferation and Differentiation of Endothelial Progenitor Cells Via Upregulating VEGF Generation.

Effect of oxidized low-density lipoprotein on survival and function of endothelial progenitor cell mediated by p38 signal pathway.

Rescuing Impaired Re-endothelialization of Drug-Eluting Stents Using the Hepatocyte Growth Factor.

Effect of Glucagon Like Peptide-1 on Proliferation and Differentiation of Endothelial Progenitor Cells and Its Mechanism

Hepatocyte Growth Factor Inhibits Hypoxia/Reoxygenation-Induced Activation Of Xanthine Oxidase In Endothelial Cells Through The Jak2 Signaling Pathway

MiR-92a regulates endothelial progenitor cells (EPCs) by targeting GDF11 via activate SMAD2/3/FAK/Akt/eNOS pathway

Hepatocyte growth factor protects human embryonic stem cell derived-neural progenitors from hydrogen peroxide-induced apoptosis.

Low-Dose Piperlongumine Rescues Impaired Function of Endothelial Progenitor Cells and Reduces Cerebral Ischemic Injury in High-Fat Diet-Fed Mice

High Density Lipoprotein Induces Rats Mesenchymal Stem Cells Proliferation Through Activating Pi3k-Akt Pathway